Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities

Diabetes Research and Clinical Practice

Volumn 84, Issue 1, 2009, Pages 27-33

  Zhuo, Qin ^a   Wang, Zhiqiang ^b   Fu, Ping ^a   Piao, Jianhua ^a   Tian, Yuan ^a   Xu, Jie ^a   Yang, Xiaoguang ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Adiponectin; Chinese older adults; Leptin; Leptin to adiponectin ratio; Metabolic syndrome

Indexed keywords

ADIPONECTIN; LEPTIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; RECEIVER OPERATING CHARACTERISTIC;

ADIPONECTIN; AGE FACTORS; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CHINA; DATA COLLECTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEPTIN; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SEX FACTORS;

EID: 62049086075     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.12.019     Document Type: Article

References (40)

1. Trayhurn P., Bing C., and Wood I.S. Adipose tissue and adipokines-energy regulation from the human perspective. J. Nutr. 136 (2006) 1935S-1939S
2. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115 (2005) 911-919 (quiz 920)
3. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86 (2001) 1930-1935
4. Hotta K., Funahashi T., Bodkin N.L., Ortmeyer H.K., Arita Y., Hansen B.C., et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50 (2001) 1126-1133
5. Berg A.H., Combs T.P., Du X., Brownlee M., and Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7 (2001) 947-953
6. Lindsay R.S., Funahashi T., Hanson R.L., Matsuzawa Y., Tanaka S., Tataranni P.A., et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360 (2002) 57-58
7. Spranger J., Kroke A., Mohlig M., Bergmann M.M., Ristow M., Boeing H., et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 361 (2003) 226-228
8. Snehalatha C., Mukesh B., Simon M., Viswanathan V., Haffner S.M., and Ramachandran A. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 26 (2003) 3226-3229
9. Duncan B.B., Schmidt M.I., Pankow J.S., Bang H., Couper D., Ballantyne C.M., et al. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 53 (2004) 2473-2478
10. Chan D.C., Watts G.F., Ng T.W., Uchida Y., Sakai N., Yamashita S., et al. Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men. Clin. Biochem. 38 (2005) 806-812
11. Farvid M.S., Ng T.W., Chan D.C., Barrett P.H., and Watts G.F. Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diabetes Obes. Metab. 7 (2005) 406-413
12. Imatoh T., Miyazaki M., Momose Y., Tanihara S., and Une H. Adiponectin levels associated with the development of hypertension: a prospective study. Hypertens. Res. 31 (2008) 229-233
13. Chow W.S., Cheung B.M., Tso A.W., Xu A., Wat N.M., Fong C.H., et al. Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 49 (2007) 1455-1461
14. Lara-Castro C., Fu Y., Chung B.H., and Garvey W.T. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr. Opin. Lipidol. 18 (2007) 263-270
15. Wang J., Li H., Franco O.H., Yu Z., Liu Y., and Lin X. Adiponectin and metabolic syndrome in middle-aged and elderly Chinese. Obesity (Silver Spring) 16 (2008) 172-178
16. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432
17. van Dijk G. The role of leptin in the regulation of energy balance and adiposity. J. Neuroendocrinol. 13 (2001) 913-921
18. Huang L., and Li C. Leptin: a multifunctional hormone. Cell Res. 10 (2000) 81-92
19. Patel S.B., Reams G.P., Spear R.M., Freeman R.H., and Villarreal D. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease. Curr. Hypertens. Rep. 10 (2008) 131-137
20. Vidal Cortada J., and Coca A. Leptin, obesity, and arterial hypertension. Med. Clin. (Barc) 126 (2006) 695-696
21. Miyanaga F., Ogawa Y., Ebihara K., Hidaka S., Tanaka T., Hayashi S., et al. Leptin as an adjunct of insulin therapy in insulin-deficient diabetes. Diabetologia 46 (2003) 1329-1337
22. Oda N., Imamura S., Fujita T., Uchida Y., Inagaki K., Kakizawa H., et al. The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism 57 (2008) 268-273
23. Satoh N., Naruse M., Usui T., Tagami T., Suganami T., Yamada K., et al. Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 27 (2004) 2488-2490
24. Mojiminiyi O.A., Abdella N.A., Al Arouj M., and Ben Nakhi A. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. Int. J. Obes. (Lond.) 31 (2007) 213-220
25. Azizi F., Salehi P., Etemadi A., and Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res. Clin. Pract. 61 (2003) 29-37
26. Pannier B., Thomas F., Eschwege E., Bean K., Benetos A., Leocmach Y., et al. Cardiovascular risk markers associated with the metabolic syndrome in a large French population: the "SYMFONIE" study. Diabetes Metab. 32 (2006) 467-474
27. Gu D., Reynolds K., Wu X., Chen J., Duan X., Reynolds R.F., et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365 (2005) 1398-1405
28. Li L.M., Rao K.Q., Kong L.Z., Yao C.H., Xiang H.D., Zhai F.Y., et al. A description on the Chinese national nutrition and health survey in 2002. Zhonghua Liu Xing Bing Xue Za Zhi (Chin. J. Epidemiol.) 26 (2005) 478-484
29. DeLong E.R., DeLong D.M., and Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44 (1988) 837-845
30. StataCorp, Stata Statistical Software: Release 10, StataCorp LP, College Station, TX, 2007.
31. Gable D.R., Hurel S.J., and Humphries S.E. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 188 (2006) 231-244
32. Hung J., McQuillan B.M., Thompson P.L., and Beilby J.P. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int. J. Obes. (Lond.) 32 (2008) 772-779
33. Ogawa Y., Kikuchi T., Nagasaki K., Hiura M., Tanaka Y., and Uchiyama M. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children. Hypertens. Res. 28 (2005) 51-57
34. Trujillo M.E., and Scherer P.E. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J. Intern. Med. 257 (2005) 167-175
35. Gannage-Yared M.H., Khalife S., Semaan M., Fares F., Jambart S., and Halaby G. Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur. J. Endocrinol. 155 (2006) 167-176
36. Franks P.W., Brage S., Luan J., Ekelund U., Rahman M., Farooqi I.S., et al. Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obes. Res. 13 (2005) 1476-1484
37. Inoue M., Yano M., Yamakado M., Maehata E., and Suzuki S. Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia. Metabolism 55 (2006) 1248-1254
38. Kumagai S., Kishimoto H., Masatakasuwa, Zou B., and Harukasasaki. The leptin to adiponectin ratio is a good biomarker for the prevalence of metabolic syndrome, dependent on visceral fat accumulation and endurance fitness in obese patients with diabetes mellitus. Metab. Syndr. Relat. Disord. 3 (2005) 85-94
39. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr. Opin. Cardiol. 21 (2006) 1-6
40. Seino Y., Hirose H., Saito I., and Itoh H. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabolism 56 (2007) 1493-1499